학술논문
Combination p53 activation and BCL-xL /BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
Document Type
Article
Author
Source
In: Leukemia . (Leukemia, June 2024, 38(6):1223-1235)
Subject
Language
English
ISSN
14765551
08876924
08876924